APA (7th ed.) Citation

Michiels, J. J., Kate, F. T., Lam, K. H., Schroyens, W., Berneman, Z., & De Raeve, H. (2014). The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation. Turkish Journal of Hematology, 31(3), 239. https://doi.org/10.4274/tjh.2013.0131

Chicago Style (17th ed.) Citation

Michiels, Jan Jacques, Fibo Ten Kate, King H. Lam, Wilfried Schroyens, Zwi Berneman, and Hendrik De Raeve. "The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation." Turkish Journal of Hematology 31, no. 3 (2014): 239. https://doi.org/10.4274/tjh.2013.0131.

MLA (9th ed.) Citation

Michiels, Jan Jacques, et al. "The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation." Turkish Journal of Hematology, vol. 31, no. 3, 2014, p. 239, https://doi.org/10.4274/tjh.2013.0131.